![Andreas M. Hohlbaum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andreas M.
Hohlbaum worked as a Scientist at Dyax Corp.
and as VP-Strategic Research & Project Management at Pieris AG.
He holds a doctorate degree from Universität Konstanz.
| Companies | Position | End |
|---|---|---|
| DYAX CORP. | Corporate Officer/Principal | - |
Pieris AG
 Pieris AG BiotechnologyHealth Technology Develops and markets an Anticalin-brand protein technology | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 3 |
|---|---|
Dyax Corp.
 Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
Pieris AG
Pieris AG BiotechnologyHealth Technology Develops and markets an Anticalin-brand protein technology | Health Technology |
Universität Konstanz
 Universität Konstanz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions
